Organization · Other
Barnik Invest Group
Barnik Invest Group is a life-science investment firm based in Solna, Sweden, focusing on early-stage and growth-stage companies in the Nordic region. The firm combines capital investment with operational support to help companies navigate clinical development and market access.
Overview
What Barnik Invest Group does
What Barnik Invest Group is
Barnik Invest Group is a life-science investment firm based in Solna, Sweden, focusing on early-stage and growth-stage companies in the Nordic region. The firm combines capital investment with operational support to help companies navigate clinical development and market access.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Other
- Founded
- Founded in 2010
- Approximate age
- About 16 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Barnik Invest Group elsewhere
Open the official website or a supported primary organization account.
Capability profile
Barnik Invest Group as a funder
Investment thesis
Barnik Invest Group identifies promising life-science companies in the Nordics, investing capital while actively supporting them with operating services to reduce commercialization bottlenecks.
Focus narrative
Barnik Invest Group focuses on investments in the life sciences sector, particularly in early-stage and growth-stage companies. Their services include capital solutions, clinical development through their subsidiary Medicorent, and commercialization support via StartUpPharma. The firm emphasizes a 360-degree approach, addressing challenges such as talent acquisition and market access.
Value beyond capital
Barnik Invest Group provides a comprehensive suite of services that includes capital solutions, clinical development support, and commercialization strategies. Their approach emphasizes hands-on assistance in navigating clinical, regulatory, and market access challenges, leveraging their subsidiaries to enhance portfolio company growth.
Focus and fit
- Stages
- Pre-seed · Seed · Growth Equity
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 5
Portfolio context
BoniPharmex: Specializes in probiotic and holistic food supplements aimed at enhancing well-being. Cell4Cure AB: Develops immune tolerance therapies using dendritic cell technology. Milmed Unico AB: Engaged in medicinal probiotic research, particularly for allergies and longevity therapies. CathPrint AB: Innovates in catheter technology, integrating electronics into catheter design for improved functionality. MedStorm Innovation AS: Focuses on real-time pain assessment technologies.
Common questions
What to know about Barnik Invest Group
Upseed classifies Barnik Invest Group under the Other organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.